Amiodarone hydrochloride and Death - a phase IV clinical study of FDA data
Summary:
Death is reported as a side effect among people who take Amiodarone hydrochloride (amiodarone hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Allopurinol, and have Dyspnea.
The study is created by eHealthMe based on reports of 9,284 people who have side effects when taking Amiodarone hydrochloride from the FDA, and is updated regularly.
What is Amiodarone hydrochloride?
Amiodarone hydrochloride has active ingredients of amiodarone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 10,061 Amiodarone hydrochloride users. Check the latest studies of Amiodarone hydrochloride.
9,284 people reported to have side effects when taking Amiodarone hydrochloride.
Among them, 295 people (3.18%) died.
Among these 295 people:
How long have people been on Amiodarone hydrochloride when they died? *
What is the gender of people who died when taking Amiodarone hydrochloride? *
What is the age of people who died when taking Amiodarone hydrochloride? *
What are other drugs people take besides Amiodarone hydrochloride? *
What are other side effects people have before they died? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Amiodarone hydrochloride:
- Amiodarone hydrochloride (10,061 reports)
Expand to all the drugs that have ingredients of amiodarone hydrochloride:
- Death and drugs with ingredients of amiodarone hydrochloride (3,460 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Amiodarone hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Death:
- Death (3,132 drugs)
Browse all the conditions that are associated with Death:
- Death (3,686 conditions)
Related publications that referenced our studies
- Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
- Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
- Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
- Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on amiodarone hydrochloride (the active ingredients of Amiodarone hydrochloride) and Amiodarone hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Nexium cause Ocular Vascular Disorder? - 2 seconds ago
- Drug interactions of Ibuprofen and Raloxifene Hydrochloride - 6 seconds ago
- Drug interactions of Prozac and Mesalamine - 8 seconds ago
- Drug interactions of Ibrutinib and Palonosetron - 8 seconds ago
- Lidocaine vs. Nabumetone, side effect and effectiveness comparison - 12 seconds ago
- How effective is Advil for Back Pain - Low? - 16 seconds ago
- Drug interactions of Ibrutinib and Januvia - 18 seconds ago
- Could Neulasta cause Anhedonia? - 22 seconds ago
- Could Blopress cause Hyperglycemia? - 24 seconds ago
- Drug interactions of Xtampza Er and Fenofibrate - 29 seconds ago